Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients

被引:27
|
作者
Boone, M. Dustin [1 ,2 ]
Celi, Leo A. [3 ,4 ]
Ho, Ben G. [4 ]
Pencina, Michael [5 ]
Curry, Michael P. [6 ,7 ]
Lior, Yotam [8 ]
Talmor, Daniel [1 ,2 ]
Novack, Victor [1 ,2 ,8 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, Dept Pulm Crit Care & Sleep Med, Boston, MA 02215 USA
[4] Harvard MIT, Div Hlth Sci Technol, Cambridge, MA USA
[5] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Dept Med, Div Hepatol, Boston, MA 02215 USA
[7] Harvard Univ, Sch Med, Boston, MA USA
[8] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Clin Res Ctr, Beer Sheva, Israel
关键词
Cirrhosis; Prognosis; Epidemiology; Outcome; Critical care; Organ dysfunction scores; INTENSIVE-CARE-UNIT; TERM MORTALITY; RISK-FACTORS; MEDICAL ICU; PROGNOSIS; MELD; SURVIVAL; DEATH;
D O I
10.1016/j.jcrc.2014.05.013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: Cirrhosis is a common condition that complicates the management of patients who require critical care. There is interest in identifying scoring systems that may be used to predict outcome because of the poor odds for recovery despite high-intensity care. We sought to evaluate how Model for End-Stage Liver Disease (MELD), an organ-specific scoring system, compares with other severity of illness scoring systems in predicting short-and long-term mortality for critically ill cirrhotic patients. Materials and methods: This was a retrospective cohort study involving seven intensive care units (ICUs) in a tertiary care, academic medical center. Adult patients with cirrhosis who were admitted to an ICU between 2001 and 2008 were evaluated. Severity of illness scores (MELD and Sequential Organ Failure Assessment [SOFA]) were calculated on admission and at 24 and 48 hours. The primary end points were 28-day and 1-year all-cause mortality. Results: Of 19742 ICU hospitalizations, 848 had cirrhosis. Relevant data were available for 521 patients (73%). Of these cases, 353 patients (69.5%) were admitted to medical ICU (MICU), and the other 155 (30.5%), to surgical unit. Alcohol abuse and hepatitis C were the most common reasons for cirrhosis. Patients who died within 28 days were more likely to receive mechanical ventilation, pressors, and renal replacement therapy. Among 353 medical admissions, both MELD and SOFA were found to be significantly associated with both 28-day and 1-year mortality. Among the 155 surgical admissions, both scores were found to be not significant for 28-day mortality but were significant for 1 year. Conclusions: Our results demonstrate that the prognostic ability of a variety of scoring systems strongly depends on the patient population. In the MICU population, each model (MELD + SOFA, MELD, and SOFA) demonstrates excellent discrimination for 28-day and 1-year mortality. However, these scoring systems did not predict 28-day mortality in the surgical ICU group but were significant for 1-year mortality. This suggests that patients admitted to a surgical ICU will behave similarly to their MICU cohort if they survive the perioperative period. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:881.e7 / 881.e13
页数:7
相关论文
共 50 条
  • [41] Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease
    Said, A
    Williams, J
    Holden, J
    Remington, P
    Gangnon, R
    Musat, A
    Lucey, MR
    JOURNAL OF HEPATOLOGY, 2004, 40 (06) : 897 - 903
  • [42] Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance
    Wernly, Bernhard
    Lichtenauer, Michael
    Franz, Marcus
    Kabisch, Bjoern
    Muessig, Johanna
    Masyuk, Maryna
    Hoppe, Uta C.
    Kelm, Malte
    Jung, Christian
    PLOS ONE, 2017, 12 (02):
  • [44] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [45] Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation
    Leibovici-Weissman, Yaara
    Mor, Eytan
    Leshno, Moshe
    Shlomai, Amir
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (03) : 801 - 807
  • [46] Patients’ Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation
    Yaara Leibovici-Weissman
    Eytan Mor
    Moshe Leshno
    Amir Shlomai
    Digestive Diseases and Sciences, 2017, 62 : 801 - 807
  • [47] Model for end-stage liver disease predicts mortality after pericardiectomy for constrictive pericarditis
    Radakovic, Darko
    Opacic, Dragan
    Boergermann, Jochen
    Hsieh, Wan Chin
    Krutzinna, Manuel
    Gummert, Jan
    Aboud, Anas
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2018, 27 (06) : 813 - 818
  • [48] The Model for End-Stage Liver Disease (MELD) score predicts survival in patients with spontaneous bacterial peritonitis, and with ascites
    Malinchoc, M
    Gines, P
    Navasa, M
    Fernandez, J
    Kim, WR
    Wiesner, RH
    Kamath, PS
    GASTROENTEROLOGY, 2001, 120 (05) : A378 - A378
  • [49] Liver fibrosis-4 score predicts mortality in critically ill patients with coronavirus disease 2019
    Abosamak, Mohammed Fawzi
    Szergyuk, Ivan
    De Oliveira, Maria Helena Santos
    Lippi, Giuseppe
    Al-Jabbary, Ahmed Suliman
    Al-Najjar, Amal H.
    Albadi, Marzooq A.
    Henry, Brandon M.
    INDIAN ANAESTHETISTS FORUM, 2021, 22 (02): : 149 - 156
  • [50] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Dolejs, Scott C.
    Beane, Joal D.
    Kays, Joshua K.
    Ceppa, Eugene P.
    Zarzaur, Ben L.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12): : 5192 - 5200